Freenome, Inc. — Company profile
United States
Last price 12.48 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.34B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Freenome, Inc., a biotechnology company, develops blood-based screening tests to detect cancer in the United States. The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated with cancer. It develops SimpleScreen™ CRC, a blood-based test, including a test for colorectal cancer screening, as well as tests for multi-cancer and multi-disease detection, such as lung, breast, cervical, liver, pancreatic, and esophageal cancers. The company was founded in 2014 and is headquartered in Brisbane, California.
Details
| Name | Freenome, Inc. |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Employees | 381 |
| Founded | 2014 |
| Ceo | Aaron Elliott |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US35661P1003 |
| Cusip | 35661P100 |
| Cik | 0002017526 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Aaron Elliott Ph.D. | Chief Executive Officer and Director |
| Riley Ennis | Co-Founder and Chief Product Officer |
| Linh H. Le | Chief Financial Officer |
| Cheng-Ho Lin M.D., MHS, Ph.D. | Chief Scientific Officer |
| Thomas F. Fitzpatrick J.D. | Chief Legal Officer |
| Julie Tran M.B.A., MSHR | Chief People Officer |
| Sally Howard J.D. | Senior Vice President of Regulatory and Quality |
| Robert Guigley | Chief Commercial Officer |
Contact
| Address | 3300 Marina Boulevard, Brisbane, California 94005, United States |
| Phone | 650 446 6630 |
| Website | https://www.freenome.com |